Lilly Insulin Glargine Versus Lantus(®) in Type 2 Diabetes Mellitus Patients: India and East Asia Subpopulation Analyses of the ELEMENT 5 Study

BACKGROUND AND OBJECTIVES: Lilly insulin glargine (LY IGlar; Basaglar(®)) and the reference insulin glargine product (IGlar; Lantus(®)) are basal insulin glargine analogs with identical amino acid sequence and similar pharmacological profiles. ELEMENT 5, a Phase 3, prospective, randomized, multinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Viswanathan, Ahn, Kyu Jeung, Cho, Young Min, Sahay, Rakesh Kumar, Huang, Chien-Ning, Kalra, Sanjay, Chadha, Manoj, Bhattacharya, Indranil, Kim, So Yeon, Spaepen, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656918/
https://www.ncbi.nlm.nih.gov/pubmed/31119716
http://dx.doi.org/10.1007/s40261-019-00798-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656918/
https://www.ncbi.nlm.nih.gov/pubmed/31119716
http://dx.doi.org/10.1007/s40261-019-00798-1

Ejemplares similares